Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.

Liu G, Cooley MA, Jarnicki AG, Borghuis T, Nair PM, Tjin G, Hsu AC, Haw TJ, Fricker M, Harrison CL, Jones B, Hansbro NG, Wark PA, Horvat JC, Argraves WS, Oliver BG, Knight DA, Burgess JK, Hansbro PM.

JCI Insight. 2019 Jul 25;5. pii: 124529. doi: 10.1172/jci.insight.124529.

2.

Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c.

Liu G, Cooley MA, Nair PM, Donovan C, Hsu AC, Jarnicki AG, Haw TJ, Hansbro NG, Ge Q, Brown AC, Tay H, Foster PS, Wark PA, Horvat JC, Bourke JE, Grainge CL, Argraves WS, Oliver BG, Knight DA, Burgess JK, Hansbro PM.

J Pathol. 2017 Dec;243(4):510-523. doi: 10.1002/path.4979.

PMID:
28862768
3.

Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Liu G, Cooley MA, Jarnicki AG, Hsu AC, Nair PM, Haw TJ, Fricker M, Gellatly SL, Kim RY, Inman MD, Tjin G, Wark PA, Walker MM, Horvat JC, Oliver BG, Argraves WS, Knight DA, Burgess JK, Hansbro PM.

JCI Insight. 2016 Jun 16;1(9). pii: e86380.

4.

Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes.

Kang I, Barth JL, Sproul EP, Yoon DW, Workman GA, Braun KR, Argraves WS, Wight TN.

J Biol Chem. 2015 Aug 28;290(35):21629-41. doi: 10.1074/jbc.M115.657486. Epub 2015 Jul 7.

5.

Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts.

Ge Q, Chen L, Jaffar J, Argraves WS, Twal WO, Hansbro P, Black JL, Burgess JK, Oliver B.

Sci Rep. 2015 Apr 2;5:9496. doi: 10.1038/srep09496.

6.

A novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunit.

Twal WO, Hammad SM, Guffy SL, Argraves WS.

Matrix Biol. 2015 Apr;43:97-108. doi: 10.1016/j.matbio.2015.01.021. Epub 2015 Feb 3.

7.

Fibulin-1 suppresses endothelial to mesenchymal transition in the proximal outflow tract.

Harikrishnan K, Cooley MA, Sugi Y, Barth JL, Rasmussen LM, Kern CB, Argraves KM, Argraves WS.

Mech Dev. 2015 May;136:123-32. doi: 10.1016/j.mod.2014.12.005. Epub 2015 Jan 6.

8.

Total and isoform-specific quantitative assessment of circulating fibulin-1 using selected reaction monitoring MS and time-resolved immunofluorometry.

Overgaard M, Cangemi C, Jensen ML, Argraves WS, Rasmussen LM.

Proteomics Clin Appl. 2015 Aug;9(7-8):767-75. doi: 10.1002/prca.201400070. Epub 2015 Jan 12.

PMID:
25331251
9.

Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).

Kruger R, Rasmussen LM, Argraves WS, Eugen-Olsen J, Nielsen OW, Blyme A, Willenheimer R, Wachtell K, Olsen MH.

PLoS One. 2014 Jul 11;9(7):e101522. doi: 10.1371/journal.pone.0101522. eCollection 2014.

10.

Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis.

Jaffar J, Unger S, Corte TJ, Keller M, Wolters PJ, Richeldi L, Cerri S, Prêle CM, Hansbro PM, Argraves WS, Oliver RA, Oliver BG, Black JL, Burgess JK.

Chest. 2014 Oct;146(4):1055-1063. doi: 10.1378/chest.13-2688.

11.

Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension.

Oxlund CS, Cangemi C, Henriksen JE, Jacobsen IA, Gram J, Schousboe K, Tarnow L, Argraves WS, Rasmussen LM.

J Hum Hypertens. 2015 Jan;29(1):28-32. doi: 10.1038/jhh.2014.27. Epub 2014 Apr 17.

PMID:
24739800
12.

3D printing facilitated scaffold-free tissue unit fabrication.

Tan Y, Richards DJ, Trusk TC, Visconti RP, Yost MJ, Kindy MS, Drake CJ, Argraves WS, Markwald RR, Mei Y.

Biofabrication. 2014 Jun;6(2):024111. doi: 10.1088/1758-5082/6/2/024111. Epub 2014 Apr 10.

13.

Helicobacter pylori-induced posttranscriptional regulation of H-K-ATPase α-subunit gene expression by miRNA.

Zhang YM, Noto JM, Hammond CE, Barth JL, Argraves WS, Backert S, Peek RM Jr, Smolka AJ.

Am J Physiol Gastrointest Liver Physiol. 2014 Apr 1;306(7):G606-13. doi: 10.1152/ajpgi.00333.2013. Epub 2014 Feb 6.

14.

Fibulins and their role in cardiovascular biology and disease.

Cangemi C, Hansen ML, Argraves WS, Rasmussen LM.

Adv Clin Chem. 2014;67:245-65. doi: 10.1016/bs.acc.2014.09.008. Epub 2014 Nov 4. Review.

PMID:
25735864
15.

Cubilin maintains blood levels of HDL and albumin.

Aseem O, Smith BT, Cooley MA, Wilkerson BA, Argraves KM, Remaley AT, Argraves WS.

J Am Soc Nephrol. 2014 May;25(5):1028-36. doi: 10.1681/ASN.2013060671. Epub 2013 Dec 19.

16.

Elevated transferrin saturation, health-related quality of life and telomere length.

Mainous AG 3rd, Wright RU, Hulihan MM, Twal WO, McLaren CE, Diaz VA, McLaren GD, Argraves WS, Grant AM.

Biometals. 2014 Feb;27(1):135-41. doi: 10.1007/s10534-013-9693-4. Epub 2013 Dec 15.

17.

Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes.

Skov V, Cangemi C, Gram J, Christensen MM, Grodum E, Sørensen D, Argraves WS, Henriksen JE, Rasmussen LM.

Diabetes Care. 2014;37(3):760-6. doi: 10.2337/dc13-1022. Epub 2013 Oct 17.

PMID:
24135389
18.

Aortic valve stenosis and atrial fibrillation influence plasma fibulin-1 levels in patients treated with coronary bypass surgery.

Hansen ML, Dahl JS, Argraves WS, Irmukhamedov A, Rasmussen LM.

Cardiology. 2013;126(3):202-6. doi: 10.1159/000354217. Epub 2013 Sep 18.

PMID:
24051963
19.

Cellularized microcarriers as adhesive building blocks for fabrication of tubular tissue constructs.

Twal WO, Klatt SC, Harikrishnan K, Gerges E, Cooley MA, Trusk TC, Zhou B, Gabr MG, Shazly T, Lessner SM, Markwald RR, Argraves WS.

Ann Biomed Eng. 2014 Jul;42(7):1470-81. doi: 10.1007/s10439-013-0883-6. Epub 2013 Aug 14.

20.

Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study.

Laugesen E, Høyem P, Christiansen JS, Knudsen ST, Hansen KW, Argraves WS, Hansen TK, Poulsen PL, Rasmussen LM.

Cardiovasc Diabetol. 2013 Jul 18;12:107. doi: 10.1186/1475-2840-12-107.

21.

Cubilin expression is monoallelic and epigenetically augmented via PPARs.

Aseem O, Barth JL, Klatt SC, Smith BT, Argraves WS.

BMC Genomics. 2013 Jun 18;14:405. doi: 10.1186/1471-2164-14-405.

22.

Telomere length and elevated iron: the influence of phenotype and HFE genotype.

Mainous AG 3rd, Wright RU, Hulihan MM, Twal WO, McLaren CE, Diaz VA, McLaren GD, Argraves WS, Grant AM.

Am J Hematol. 2013 Jun;88(6):492-6. doi: 10.1002/ajh.23438. Epub 2013 May 13.

23.

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.

Scholze A, Bladbjerg EM, Sidelmann JJ, Diederichsen AC, Mickley H, Nybo M, Argraves WS, Marckmann P, Rasmussen LM.

Cardiovasc Diabetol. 2013 Jan 7;12:6. doi: 10.1186/1475-2840-12-6.

24.

A cytokine axis regulates elastin formation and degradation.

Sproul EP, Argraves WS.

Matrix Biol. 2013 Mar 11;32(2):86-94. doi: 10.1016/j.matbio.2012.11.004. Epub 2012 Nov 13. Review.

25.
26.

Microarray analysis of normal and abnormal chick ventricular myocardial development.

Krejčí E, Pesevski Z, DeAlmeida AC, Mrug M, Fresco VM, Argraves WS, Barth JL, Cui X, Sedmera D.

Physiol Res. 2012;61 Suppl 1:S137-44.

27.

Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation.

Zyblewski SC, Argraves WS, Graham EM, Slate EH, Atz AM, Bradley SM, McQuinn TC, Wilkerson BA, Wing SB, Argraves KM.

Pediatr Cardiol. 2012 Oct;33(7):1154-9. doi: 10.1007/s00246-012-0274-z. Epub 2012 Mar 13.

28.

NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study.

Kruger R, Schutte R, Huisman HW, Argraves WS, Rasmussen LM, Olsen MH, Schutte AE.

Atherosclerosis. 2012 May;222(1):216-21. doi: 10.1016/j.atherosclerosis.2012.01.045. Epub 2012 Feb 3.

PMID:
22349089
29.

Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.

Cooley MA, Fresco VM, Dorlon ME, Twal WO, Lee NV, Barth JL, Kern CB, Iruela-Arispe ML, Argraves WS.

Dev Dyn. 2012 Feb;241(2):303-14. doi: 10.1002/dvdy.23716. Epub 2011 Dec 19.

30.

Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes.

Cangemi C, Skov V, Poulsen MK, Funder J, Twal WO, Gall MA, Hjortdal V, Jespersen ML, Kruse TA, Aagard J, Parving HH, Knudsen S, Høilund-Carlsen PF, Rossing P, Henriksen JE, Argraves WS, Rasmussen LM.

Clin Chem. 2011 Nov;57(11):1556-65. doi: 10.1373/clinchem.2011.162966. Epub 2011 Sep 16.

31.

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.

Argraves KM, Sethi AA, Gazzolo PJ, Wilkerson BA, Remaley AT, Tybjaerg-Hansen A, Nordestgaard BG, Yeatts SD, Nicholas KS, Barth JL, Argraves WS.

Lipids Health Dis. 2011 May 9;10:70. doi: 10.1186/1476-511X-10-70.

32.

Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis.

Argraves KM, Wilkerson BA, Argraves WS.

World J Biol Chem. 2010 Oct 26;1(10):291-7. doi: 10.4331/wjbc.v1.i10.291.

33.

Collective cell motion in endothelial monolayers.

Szabó A, Unnep R, Méhes E, Twal WO, Argraves WS, Cao Y, Czirók A.

Phys Biol. 2010 Nov 12;7(4):046007. doi: 10.1088/1478-3975/7/4/046007.

34.

Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis.

Barth JL, Clark CD, Fresco VM, Knoll EP, Lee B, Argraves WS, Lee KH.

Dev Dyn. 2010 Jul;239(7):2024-33. doi: 10.1002/dvdy.22341.

35.

GeneMesh: a web-based microarray analysis tool for relating differentially expressed genes to MeSH terms.

Jani SD, Argraves GL, Barth JL, Argraves WS.

BMC Bioinformatics. 2010 Apr 1;11:166. doi: 10.1186/1471-2105-11-166.

36.

Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.

Kern CB, Wessels A, McGarity J, Dixon LJ, Alston E, Argraves WS, Geeting D, Nelson CM, Menick DR, Apte SS.

Matrix Biol. 2010 May;29(4):304-16. doi: 10.1016/j.matbio.2010.01.005. Epub 2010 Jan 22.

37.

ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression.

McCulloch DR, Nelson CM, Dixon LJ, Silver DL, Wylie JD, Lindner V, Sasaki T, Cooley MA, Argraves WS, Apte SS.

Dev Cell. 2009 Nov;17(5):687-98. doi: 10.1016/j.devcel.2009.09.008.

38.

Fusion of uniluminal vascular spheroids: a model for assembly of blood vessels.

Fleming PA, Argraves WS, Gentile C, Neagu A, Forgacs G, Drake CJ.

Dev Dyn. 2010 Feb;239(2):398-406. doi: 10.1002/dvdy.22161.

39.

Fibulin-1 and fibrinogen in human atherosclerotic lesions.

Argraves WS, Tanaka A, Smith EP, Twal WO, Argraves KM, Fan D, Haudenschild CC.

Histochem Cell Biol. 2009 Nov;132(5):559-65. doi: 10.1007/s00418-009-0628-7. Epub 2009 Aug 20.

PMID:
19693531
40.

Expression of Patched-1 and Smoothened in testicular meiotic and post-meiotic cells.

Morales CR, Fox A, El-Alfy M, Ni X, Argraves WS.

Microsc Res Tech. 2009 Nov;72(11):809-15. doi: 10.1002/jemt.20733.

PMID:
19484749
41.

Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1.

Courtney HS, Li Y, Twal WO, Argraves WS.

J Biol Chem. 2009 May 8;284(19):12966-71. doi: 10.1074/jbc.M901143200. Epub 2009 Mar 10.

42.

Effects of spaceflight on murine skeletal muscle gene expression.

Allen DL, Bandstra ER, Harrison BC, Thorng S, Stodieck LS, Kostenuik PJ, Morony S, Lacey DL, Hammond TG, Leinwand LL, Argraves WS, Bateman TA, Barth JL.

J Appl Physiol (1985). 2009 Feb;106(2):582-95. doi: 10.1152/japplphysiol.90780.2008. Epub 2008 Dec 12. Erratum in: J Appl Physiol. 2011 Jan;110(1):298.

43.

VEGF-mediated fusion in the generation of uniluminal vascular spheroids.

Gentile C, Fleming PA, Mironov V, Argraves KM, Argraves WS, Drake CJ.

Dev Dyn. 2008 Oct;237(10):2918-25. doi: 10.1002/dvdy.21720.

44.

ATP-binding cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa.

Morales CR, Marat AL, Ni X, Yu Y, Oko R, Smith BT, Argraves WS.

Biochem Biophys Res Commun. 2008 Nov 21;376(3):472-7. doi: 10.1016/j.bbrc.2008.09.009. Epub 2008 Sep 13.

45.

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.

Argraves KM, Gazzolo PJ, Groh EM, Wilkerson BA, Matsuura BS, Twal WO, Hammad SM, Argraves WS.

J Biol Chem. 2008 Sep 5;283(36):25074-81. doi: 10.1074/jbc.M801214200. Epub 2008 Jul 7.

46.

Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.

Hammad SM, Twal WO, Barth JL, Smith KJ, Saad AF, Virella G, Argraves WS, Lopes-Virella MF.

Atherosclerosis. 2009 Feb;202(2):394-404. doi: 10.1016/j.atherosclerosis.2008.05.032. Epub 2008 May 28.

47.

Fibulin-1 is required for morphogenesis of neural crest-derived structures.

Cooley MA, Kern CB, Fresco VM, Wessels A, Thompson RP, McQuinn TC, Twal WO, Mjaatvedt CH, Drake CJ, Argraves WS.

Dev Biol. 2008 Jul 15;319(2):336-45. doi: 10.1016/j.ydbio.2008.04.029. Epub 2008 May 3.

48.

The genetics of vasculogenesis.

Drake CJ, Fleming PA, Argraves WS.

Novartis Found Symp. 2007;283:61-71; discussion 71-6, 238-41.

PMID:
18300414
49.

Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development.

Wirrig EE, Snarr BS, Chintalapudi MR, O'neal JL, Phelps AL, Barth JL, Fresco VM, Kern CB, Mjaatvedt CH, Toole BP, Hoffman S, Trusk TC, Argraves WS, Wessels A.

Dev Biol. 2007 Oct 15;310(2):291-303. Epub 2007 Aug 9.

50.

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.

Argraves KM, Argraves WS.

J Lipid Res. 2007 Nov;48(11):2325-33. Epub 2007 Aug 13. Review.

Supplemental Content

Loading ...
Support Center